Search clinical trials for: Fexofenadine, Comparator = Montelukast

Total 2373 results

Sanofi

Completed

Long-Term Safety Performance of Fexofenadine in Asthma

Asthma

United States
Clinical Nutrition Research Center, Illinois Institute...

Completed

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance (GSE3)

Impaired Glucose Tolerance

United States
Merck Sharp & Dohme LLC

Completed

MK0524 Asthma POC Study (0524-008)(COMPLETED)

Asthma
Organon and Co

Completed

The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)

Exercise-induced Bronchoconstriction (EIB)
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

Asthma, Exercise-Induced
Organon and Co

Completed

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

Asthma, Exercise-Induced
Organon and Co

Completed

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

Asthma, Exercise-Induced
Organon and Co

Completed

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

Asthma
University of Brasilia

Completed

Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

Asthma
Organon and Co

Completed

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

Chronic Asthma
Organon and Co

Completed

A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast Back to School Asthma Study (0476-340)

Asthma
Organon and Co

Completed

Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )

Asthma
Organon and Co

Completed

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

Rhinitis, Allergic, Perennial | Asthma, Bronchial
Organon and Co

Completed

An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)

Bronchiolitis
Organon and Co

Completed

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

Asthma
Organon and Co

Completed

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

Perennial Allergic Rhinitis
Bayer

Completed

A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)

Rhinitis
Organon and Co

Completed

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

Asthma
Organon and Co

Completed

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

Rhinitis, Allergic, Seasonal | Asthma, Bronchial
Organon and Co

Completed

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Acute Asthma (0476-322)

Asthma
Organon and Co

Completed

Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)

Asthma
Merck Sharp & Dohme LLC

Completed

Early Airway Response to Allergen in Asthmatics (MK-0000-176)

Asthma
Organon and Co

Completed

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

Asthma
Organon and Co

Completed

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

Asthma
Organon and Co

Completed

Exercise Induced Bronchoconstriction (0476-359)

Asthma, Exercise-induced
Pfizer

Terminated

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Healthy

Singapore
Organon and Co

Completed

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

Seasonal Allergic Rhinitis
Indiana University

Completed

Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in Asthma

Asthma

United States
Chinese University of Hong Kong
University of Sydney; Chongqing Medical University; Hong Kong University of Science... and other collaborators

Not yet recruiting

Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China

Atherosclerosis, Coronary

Hong Kong
Organon and Co

Completed

Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)

Asthma
Opella Healthcare Group SAS, a Sanofi Company

Recruiting

Bioavailability Study of Fexofenadine HCl New Formulation Tablet

Healthy Volunteers

Canada
Sanofi

Completed

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis

United States
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Seasonal Allergic Rhinitis
Sanofi

Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Japan
Tanta University

Completed

Role of Fexofenadine in Diabetic Kidney Disease

Diabetic Kidney Disease

Egypt
University of California, San Francisco
Food and Drug Administration (FDA)

Recruiting

Excipient Effect on Drug Absorption in Humans

The Impact of Excipients on Drug Absorption

United States
Eisai Inc.

Completed

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Alzheimer's Disease

United States
Ardea Biosciences, Inc.

Completed

Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors (LIGHT)

Gout

United States, Canada, South Africa, New Zealand, Belgium, Australia, Germany
GlaxoSmithKline

Completed

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

Respiratory Disorders

India
Sanofi

Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

Rhinitis Perennial

Japan
Sanofi

Completed

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

Cat Induced Allergic Rhinitis
Organon and Co

Completed

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Rhinitis Allergic
Merck Sharp & Dohme LLC

Withdrawn

A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)

Breast Cancer

3

Subscribe